Published on 30 March 2026
Description:
This month’s edition reimagines the NHS dichotomy as a dystopian game of Tetris - we investigate which parties might finally shake things up. We explore the GLP-1 explosion and how its boom will mold the medicines of the future. Plus, deep dives into AI in pharma, reproductive health in 2026, life sciences’ greatest hits, and the global impact of Trump’s healthcare decisions. Finally, comms guru Jess ‘Pharmery’ Farmery sparkles in her highly anticipated debut.
Categories:
PharmaTimesPreview:
25 articles from this collection:
PT April 2026
2 Communiqué Awards Ad
3 From the editor
4-5 Contents
6 NEWS: Treatments
7 NEWS: Approvals
8 NEWS: Clinical Trials
9 NEWS: Conditions
10-12 COVER STORY: Apocalypse now?
13 PMI Awards & PharmaTimes
16-17 GLP-1 - Big appetite
18-19 WOMEN IN PHARMA - Leading by example
20-21 INTERNATIONAL - Out of Africa
22-23 PHARMA - Fast and the curious
24 FARMERY’S COMMS CORNER - Talking the talk
25 - Samedan
26-27 REPRODUCTION - Being is believing?
28-29 PUBLIC HEALTH - Urban hype
30-31 CONDITIONS - Wake-up call
32-34 CANCER - New wave
35 PMPS
36-37 Your Moves
38 AI - Control peak
39 - International Clinical Researcher of the Year
40 FlyPharma
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.